I can help with a quick summary, but I don’t have live access to the latest headlines right now. Here’s what’s commonly tracked about Lilly (Eli Lilly) recently, based on typical latest-news themes:
- Weight-loss and diabetes therapies: Lilly’s obesity and diabetes treatments (such as tirzepatide products) have been focal points, including regulatory discussions and new study results. Expect updates on FDA priority reviews, trial outcomes, and any approved indications or label expansions. [cited sources would be needed for specifics]
- Corporate updates: Company earnings, pipeline progress, manufacturing investments, and acquisitions or partnerships often appear in the latest news cycle.
- Market and regulatory context: News about pricing, access programs, and competitive developments with peers in GLP-1 therapies (e.g., Novo Nordisk) are frequently covered.
If you’d like, I can pull in up-to-date articles and summarize them, with citations, and I can also tailor the update to a specific angle (e.g., stock impact, regulatory news, or clinical trial results). Would you like me to fetch the latest headlines and provide a concise briefing with sources?
Sources
Find the latest news about Eli Lilly and Company.
www.lilly.comLatest news on on Eli Lilly and Company, an American pharmaceutical with headquarters in Indianapolis.
www.newsnow.co.ukThe Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.
investor.lilly.comnews
www.prnewswire.comEli Lilly (LLY) Latest News & Updates – Why is it moving? What’s happening today? Get real-time market sentiment and stock updates
public.comnews
www.prnewswire.comTwo cats in separate New York City households have tested positive for bird flu, the city health department says. Tracy Morgan had a health scare and was seen getting sick during the Knicks-Heat game Monday at Madison Square Garden in NYC. Sean "Diddy" Combs' trial for federal sex trafficking charges will begin a week later than expected, a judge in Manhattan ruled Friday.
www.cbsnews.comDrugmaker Eli Lilly said Thursday that things are looking good for their latest weight loss drug that would be available as a pill. Dr. Jon LaPook reports. Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual agreement." … Shares of the pharmaceutical company jumped almost 5% after announcing promising results for donanemab. Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for...
www.cbsnews.comLilly unites caring with discovery to create medicines that make life better for people around the world.
www.lilly.comLilly unites caring with discovery to create medicines that make life better for people around the world.
www.lilly.com